The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The BRIGHTER trial: A phase III randomized double-blind study of BBI-608 + weekly paclitaxel versus placebo (PBO) + weekly paclitaxel in patients (pts) with pretreated advanced gastric and gastro-esophageal junction (GEJ) adenocarcinoma.
 
Manish A. Shah
Consulting or Advisory Role - Lilly
Research Funding - Genentech (Inst); Sanofi (Inst)
 
Kei Muro
Honoraria - Chugai Pharma; Takeda; Yakult Honsha
Consulting or Advisory Role - Takeda
 
Kohei Shitara
No Relationships to Disclose
 
Niall C. Tebbutt
No Relationships to Disclose
 
Yung-Jue Bang
No Relationships to Disclose
 
Florian Lordick
Honoraria - Amgen; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Nordic Group; Roche Pharma AG
Consulting or Advisory Role - BioNTech; GANYMED Pharmaceuticals; Roche (Inst)
Research Funding - Boehringer Ingelheim (Inst); Fresenius Biotech; GlaxoSmithKline (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - Bayer; Roche; Taiho Pharmaceutical
 
Laura Borodyansky
Employment - Boston Biomedical
 
Chiang Li
Employment - Boston Biomedical
Leadership - Boston Biomedical
Stock and Other Ownership Interests - Boston Biomedical
Patents, Royalties, Other Intellectual Property - Boston Biomedal